Hikma Pharmaceuticals Plc PE Ratio 2016-2018 | HKMPF

Current and historical p/e ratio for Hikma Pharmaceuticals Plc (HKMPF) from 2016 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Hikma Pharmaceuticals Plc PE ratio as of February 25, 2020 is 0.00.
Hikma Pharmaceuticals Plc PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.877B $2.070B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.031B 37.04
Takeda Pharmaceutical (TAK) Japan $56.514B 10.02
Astellas Pharma (ALPMY) Japan $30.561B 15.26
Eisai (ESALY) Japan $22.212B 42.82
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $16.845B 22.07
Merck (MKGAF) Germany $16.330B 22.28
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.702B 241.77
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.012B 32.96
Ionis Pharmaceuticals (IONS) United States $7.779B 15.76
Jazz Pharmaceuticals (JAZZ) Ireland $7.199B 8.71
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.849B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.137B 15.63
United Therapeutics (UTHR) United States $4.952B 0.00
Nektar Therapeutics (NKTR) United States $3.897B 0.00
FibroGen (FGEN) United States $3.748B 110.15
Evotec AG (EVTCY) Germany $3.575B 57.69
Arrowhead Pharmaceuticals (ARWR) United States $3.468B 64.38
Sage Therapeutics (SAGE) United States $3.340B 0.00
PTC Therapeutics (PTCT) United States $3.255B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.816B 11.39
ChemoCentryx (CCXI) United States $2.692B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.020B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.945B 53.19
Xencor (XNCR) United States $1.820B 74.63
Ironwood Pharmaceuticals (IRWD) United States $1.750B 21.27
Heron Therapeutics (HRTX) United States $1.724B 0.00
Tilray (TLRY) Canada $1.665B 0.00
Corcept Therapeutics (CORT) United States $1.524B 17.05
Endo (ENDP) Ireland $1.481B 2.72
USANA Health Sciences (USNA) United States $1.440B 15.05
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.424B 9.71
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.309B 0.00
Zogenix (ZGNX) United States $1.239B 0.00
Akebia Therapeutics (AKBA) United States $1.059B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.013B 31.40
Portola Pharmaceuticals (PTLA) United States $0.984B 0.00
Karyopharm Therapeutics (KPTI) United States $0.911B 0.00
Aerie Pharmaceuticals (AERI) United States $0.870B 0.00
Radius Health (RDUS) United States $0.826B 0.00
Collegium Pharmaceutical (COLL) United States $0.772B 0.00
ImmunoGen (IMGN) United States $0.716B 0.00
Flexion Therapeutics (FLXN) United States $0.620B 0.00
Molecular Templates (MTEM) United States $0.620B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.524B 0.00
TherapeuticsMD (TXMD) United States $0.502B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.467B 56.63
Ardelyx (ARDX) United States $0.460B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Translate Bio (TBIO) United States $0.437B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 18.59
Aptorum Group (APM) Hong Kong, SAR China $0.417B 0.00
Organogenesis Holdings (ORGO) United States $0.412B 0.00
Calithera Biosciences (CALA) United States $0.391B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.383B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Indivior (INVVY) United States $0.369B 2.19
Lannett Co Inc (LCI) United States $0.363B 5.84
Rigel Pharmaceuticals (RIGL) United States $0.360B 0.00
DURECT (DRRX) United States $0.358B 0.00
Harpoon Therapeutics (HARP) United States $0.357B 0.00
Recro Pharma (REPH) United States $0.352B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.336B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.334B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Rafael Holdings (RFL) United States $0.309B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.302B 0.00
OptiNose (OPTN) United States $0.280B 0.00
Ocular Therapeutix (OCUL) United States $0.241B 0.00
KalVista Pharmaceuticals (KALV) United States $0.238B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.238B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.192B 0.00
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 2.48
Matinas Biopharma Holdings (MTNB) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.17
IMV INC (IMV) Canada $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.118B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.117B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.109B 0.00
CannTrust Holdings (CTST) Canada $0.108B 0.00
Otonomy (OTIC) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Redhill Biopharma (RDHL) Israel $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
CV Sciences (CVSI) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.074B 0.00
MediWound (MDWD) Israel $0.073B 0.00
Onconova Therapeutics (ONTX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.064B 19.27
CTI BioPharma (CTIC) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
VAXART, INC (VXRT) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.057B 0.00
IsoRay (ISR) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Vical (BBI) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00